Want to see RPID full AI Analyst Report?
Total Valuation
Rapid Micro Biosystems has a market cap or net worth of $88.18M. The enterprise value is $86.04M.
Market Cap$88.18M
Enterprise Value$86.04M
Share Statistics
Rapid Micro Biosystems has 45,322,280 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding45,322,280
Owned by Insiders33.01%
Owned by Institutions28.12%
Financial Efficiency
Rapid Micro Biosystems’s return on equity (ROE) is -1.42 and return on invested capital (ROIC) is -82.19%.
Return on Equity (ROE)-1.42
Return on Assets (ROA)-0.63
Return on Invested Capital (ROIC)-82.19%
Return on Capital Employed (ROCE)-0.84
Revenue Per Employee206.06K
Profits Per Employee-289.10K
Employee Count163
Asset Turnover0.45
Inventory Turnover1.48
Valuation Ratios
The current PE Ratio of Rapid Micro Biosystems is ―. Rapid Micro Biosystems’s PEG ratio is 0.99.
PE Ratio―
PS Ratio3.86
PB Ratio3.90
Price to Fair Value3.90
Price to FCF-4.06
Price to Operating Cash Flow-2.13
PEG Ratio0.99
Income Statement
In the last 12 months, Rapid Micro Biosystems had revenue of 33.59M and earned -47.12M in profits. Earnings per share was -1.05.
Revenue33.59M
Gross Profit7.61M
Operating Income-47.39M
Pretax Income-47.08M
Net Income-47.12M
EBITDA-42.74M
Earnings Per Share (EPS)-1.05
Cash Flow
In the last 12 months, operating cash flow was -37.05M and capital expenditures -925.00K, giving a free cash flow of -37.98M billion.
Operating Cash Flow-37.05M
Free Cash Flow-37.98M
Free Cash Flow per Share-0.84
Dividends & Yields
Rapid Micro Biosystems pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.10
52-Week Price Change-49.86%
50-Day Moving Average2.04
200-Day Moving Average3.06
Relative Strength Index (RSI)39.76
Average Volume (3m)253.56K
Important Dates
Rapid Micro Biosystems upcoming earnings date is Jul 31, 2026, After Close (Confirmed).
Last Earnings DateMay 13, 2026
Next Earnings DateJul 31, 2026
Ex-Dividend Date―
Financial Position
Rapid Micro Biosystems as a current ratio of 3.31, with Debt / Equity ratio of 116.24%
Current Ratio3.31
Quick Ratio2.36
Debt to Market Cap0.15
Net Debt to EBITDA-0.09
Interest Coverage Ratio-43.48
Taxes
In the past 12 months, Rapid Micro Biosystems has paid 40.00K in taxes.
Income Tax40.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Rapid Micro Biosystems EV to EBITDA ratio is -3.12, with an EV/FCF ratio of -4.18.
EV to Sales3.97
EV to EBITDA-3.12
EV to Free Cash Flow-4.18
EV to Operating Cash Flow-4.30
Balance Sheet
Rapid Micro Biosystems has $22.95M in cash and marketable securities with $23.71M in debt, giving a net cash position of -$761.00K billion.
Cash & Marketable Securities$22.95M
Total Debt$23.71M
Net Cash-$761.00K
Net Cash Per Share-$0.02
Tangible Book Value Per Share$0.74
Margins
Gross margin is 12.40%, with operating margin of -141.10%, and net profit margin of -140.30%.
Gross Margin12.40%
Operating Margin-141.10%
Pretax Margin-140.18%
Net Profit Margin-140.30%
EBITDA Margin-127.25%
EBIT Margin-136.94%
Analyst Forecast
The average price target for Rapid Micro Biosystems is $6.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$6.67
Price Target Upside192.40% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast15.99%
EPS Growth Forecast-8.91%